U.S. biopharmaceutical exports support jobs, innovation

The U.S. Census Bureau and the U.S. Bureau of Economic Analysis recently published annual trade data indicating that U.S. exports of goods exceeded $2 trillion in 2022. According to the report, U.S....
Read More
ICYMI: New research builds upon growing body of evidence on value of COVID-19 treatments and vaccines

Innovative biopharmaceutical research companies have been dedicated to fighting COVID-19 for over two years. Since the start of the pandemic, America’s biopharmaceutical companies have worked around...
Read More
The Senate’s latest price setting proposal will undermine U.S. economic growth

Last week, we examined ways the latest drug pricing proposal will undermine patient access to medicines, American medical innovation and our health care system as a whole. But there is another...
Read More
ICYMI: A patient, physician, biotech investor and industry leaders warn about the dangers of government price setting bill

During a widely attended media briefing, physicians, biopharmaceutical leaders, and a brave cancer survivor, all expressed their strong opposition to the extreme drug pricing bill Congress is...
Read More
PhRMA member companies’ R&D investments reach record high of $102.3 billion in 2021

PhRMA member companies’ continued investment in research and development (R&D) has led to new medicines transforming human health. Innovative biopharmaceutical approaches to treating patients for a...
Read More
Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US

Our industry continues working to improve patient access and affordability for medicines at the state level. I recently had the opportunity to connect with PhRMA board member Mark Reisenauer,...
Read More
COVID-19 vaccines and treatments helped save millions of lives and billions in health care costs

As the world braves year three of the COVID-19 pandemic and confronts a virus that continues to evolve and challenge us, we’ve come a long way in how we combat this ongoing threat. Since the start of...
Read More
Biopharmaceutical industry drives economic growth in all 50 states

The innovative biopharmaceutical industry has long been a significant driver of the nation’s economic growth and a key contributor to state and regional economies. A new report from TEConomy Partners...
Read More
PhRMA member companies’ R&D investments reach record high of $91.1 billion in 2020

PhRMA member companies’ robust investment in research and development (R&D) has led to advances and discoveries that are transforming health care and our approach to treating patients for a broad...
Read More
Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been...
Read More